SNU-81 Cells
759,00 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | The SNU-81 cell line is a human colorectal carcinoma model established from a Korean patient. It is part of a collection of 12 colorectal cancer cell lines derived from both primary tumors and metastatic sites, providing a diverse representation of tumor biology. SNU-81 was derived from a primary colorectal adenocarcinoma and exhibits epithelial morphology with adherent growth in culture. The cell line expresses carcinoembryonic antigen (CEA), which is secreted into the culture supernatant, reflecting typical colorectal tumor characteristics. At the molecular level, SNU-81 has undergone extensive genetic characterization. It harbors a mutation in the TP53 tumor suppressor gene, a common event in colorectal carcinogenesis, typically associated with later stages of tumor progression. Additionally, mutations in the APC gene were identified, implicating disruption of Wnt/β-catenin signaling, a hallmark of colorectal cancer development. No activating mutations were detected in the K-ras2 gene for this line. Alterations in cell cycle regulators, such as hypermethylation of the p16 gene, were also observed, further supporting the cell line's utility in studying genetic and epigenetic mechanisms driving colorectal cancer. Overall, SNU-81 serves as a well-defined in vitro model for exploring tumor suppressor gene function, oncogenic pathway regulation, and response to targeted therapies in colorectal cancer research. |
|---|---|
| Organisme | Human |
| Tissu | Colon |
| Maladie | Adenocarcinoma |
| Synonymes | SNU81, NCI-SNU-81 |
Caractéristiques
| Âge | 53 years |
|---|---|
| Genre | Male |
| Origine ethnique | Korean |
| Morphologie | Epithelial-like |
| Type de cellule | Epithelial |
| Propriétés de croissance | Adherent, monolayer |
Données réglementaires
| Référence | SNU-81 (Cytion catalog number 305638) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Cellosaurus - Numéro d'enregistrement | CVCL_5098 |
Données biomoléculaires
| Profil mutationnel | Mutation: APC, Simple, p.Ser1392Ter (c.4175C>A), Heterozygous; Mutation: APC, Simple, p.Arg1450Ter (c.4348C>T), Heterozygous; Mutation: APC, Simple, p.Arg2204Ter (c.6610C>T), Heterozygous; Mutation: FBXW7, Simple, p.Arg479Gln (c.1436G>A), Heterozygous; Mutation: KRAS, Simple, p.Ala146Thr (c.436G>A), Heterozygous; Mutation: PTEN, Simple, p.Arg130Gln (c.389G>A), Heterozygous; Mutation: PTEN, Simple, p.Glu299Ter (c.895G>T), Heterozygous; Mutation: TBX3, Simple, p.Glu111Ter (c.331G>T), Heterozygous; Mutation: TBX3, Simple, c.942-1G>T, Heterozygous; Mutation: TP53, Simple, p.Lys132Thr (c.395A>C), Heterozygous; Mutation: TP53, Simple, p.Arg213Ter (c.637C>T), Heterozygous |
|---|
Manipulation
| Milieu de culture | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suppléments | Supplement the medium with 10% FBS |
| Réactif de dissociation | Accutase |
| Temps de doublement | 30 hours |
| Repiquage | Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37''''C for 3 to 5 minutes, add culture medium and collect the cells, transfer the medium into 15ml tube, centrifuge, aspirate the medium, resuspend the pellets with culture medium and dispense into the culture flask |
| Renouvellement des fluides | 2 to 3 times per week |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificat d'analyse (CoA)
| Numéro de lot | Type de certificat | Date | Numéro de catalogue |
|---|---|---|---|
| 305638-061125 | Certificat d'analyse | 11. Dec. 2025 | 305638 |